By Kosaku Narioka
Shares of Asian drugmakers are falling after President Trump said he would sign an executive order aimed at lowering the cost of prescription drugs. The share-price moves presage possible trouble for U.S. drug stocks.
Shares of Japan's Daiichi Sankyo, which gets about a third of its revenue from the U.S., were down more than 7% in Tokyo trading Monday, with other Japanese drug stocks also lower. Pharmaceutical stocks were broadly weaker in China too.
Many global drug companies count on the U.S. for revenue and profit because U.S. drug prices tend to be higher. In other developed nations, governments typically negotiate or set a single nationwide price for drugs, using their leverage to push down the price.
In a Truth Social post, Trump said that under his plan to be announced Monday, the U.S. "will pay the same price as the Nation that pays the lowest price anywhere in the World." He didn't give details or say whether his executive order would apply to Medicare, Medicaid or other U.S. government programs.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
May 12, 2025 00:05 ET (04:05 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。